Jubilant Ingrevia has entered into the Share Purchase Agreement with Remidex Pharma (Remidex) for acquisition of its 100% stake. After acquisition Remidex will become wholly owned subsidiary of the Company.
This acquisition will enable Jubilant Ingrevia to move forward in the value chain towards Premixes in Human Nutrition Space building upon its leadership position in Vitamins (Vitamin B3 & B4). Cost of acquisition is Rs 16.5 crore subject to customary closing conditions. The said acquisition is expected to be completed in 30 days.
Jubilant Ingrevia, a global integrated Life Science products and Innovative Solutions provider serving, Pharmaceutical, Nutrition, Agrochemical, Consumer and Industrial customers.
| Company Name | CMP |
|---|---|
| BASF India | 3611.60 |
| Tata Chemicals | 690.25 |
| SRF | 2471.15 |
| Pidilite Inds. | 1360.30 |
| Deepak Nitrite | 1465.55 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: